BioXcel Therapeutics, Inc.
They are a clinical stage biopharmaceutical company focused on drug development that utilizes novel artificial intelligence, or AI, to identify the next wave of medicines across neuroscience and immuno-oncology.
$11.00 - $13.00
March 8, 2018
Barclays, UBS Investment Bank, BMO Capital Markets
To view the prospectus for BioXcel Therapeutics, Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277